A Biomarker Study to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma

NCT07063758 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Taiwan University Clinical Trial Center